The indemnity will not just impact domestic rules but also set a precedent for the future with other drug-makers also expected to seek similar facility for life-saving medicines. In addition, this could be demanded for other purchases too. The demand for an overseas jurisdiction for resolving disputes in particular has seen the Centre consider the consequences.source https://timesofindia.indiatimes.com/india/government-still-seeking-middle-path-on-vaccine-indemnity-demand/articleshow/83293261.cms
Comments
Post a Comment